尼丁醇在骨科应用中:临床见解,性能挑战和未来方向
Niyou Wang1, Veluru Jagadeesh Babu2, Namith Rangaswamy2
1Department of Mechanical Engineering, National University of Singapore, Singapore, Singapore.
概括
尼丁醇是一种具有独特特性的材料,对先进的脊柱植入物具有很大的潜力. 它在微创手术和运动保存中的使用提供了更好的结果和更好的与骨组织的整合.
科学领域:
- 生物材料科学 生物材料科学
- 整形外科手术 整形外科手术
- 材料工程 材料工程 材料工程
背景情况:
- 脊柱疾病正在增加,推动对创新的植入物解决方案的需求.
- 尼丁醇具有独特的形状记忆和超弹性特性,非常适合骨整合.
- 尼丁醇的机械兼容性适合脊柱植入物用于最少的侵入性手术和运动保存.
研究的目的:
- 提供Nitinol在骨科的临床应用的全面审查,重点是脊柱手术.
- 探索Nitinol在脊柱植入物中的材料特性,设备类型和性能益处.
- 讨论尼丁醇用于脊柱应用的新兴趋势和挑战.
主要方法:
- 临床应用,材料特性和设备类型的文献综述.
- 对性能益处的分析,包括应力屏蔽和植入物-组织集成.
- 讨论案例研究,新兴技术和挑战.
主要成果:
- 基于尼丁醇的设备 (螺丝,板,杆等) 在脊柱手术中表现有前途.
- 益处包括减少应力屏蔽和增强植入物-组织集成.
- 新兴应用包括通过增材制造和智能Nitinol系统的患者特定植入物.
结论:
- 尼丁醇植入物为脊柱应用提供了重要的临床潜力.
- 需要进一步的研究和开发,以应对热控制,制造和监管方面的挑战.
- 尼丁醇有望安全,有效和可扩展地整合到骨科实践中.
相关概念视频
Local Anesthetics: Clinical Application as Spinal Anesthesia
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
Drug Product Performance: In Vitro–In Vivo Correlation
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).


